Advisory Services Network LLC Acquires 4,893 Shares of CVS Health Corp (CVS)

Advisory Services Network LLC raised its position in CVS Health Corp (NYSE:CVS) by 44.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 15,949 shares of the pharmacy operator’s stock after purchasing an additional 4,893 shares during the quarter. Advisory Services Network LLC’s holdings in CVS Health were worth $1,283,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Afam Capital Inc. raised its stake in shares of CVS Health by 4.2% in the 2nd quarter. Afam Capital Inc. now owns 48,797 shares of the pharmacy operator’s stock valued at $3,926,000 after acquiring an additional 1,953 shares during the period. Beaton Management Co. Inc. purchased a new stake in shares of CVS Health in the 2nd quarter valued at approximately $417,000. Auxier Asset Management raised its stake in shares of CVS Health by 0.6% in the 2nd quarter. Auxier Asset Management now owns 67,449 shares of the pharmacy operator’s stock valued at $5,427,000 after acquiring an additional 400 shares during the period. Wasatch Advisors Inc. raised its stake in shares of CVS Health by 2.4% in the 2nd quarter. Wasatch Advisors Inc. now owns 86,060 shares of the pharmacy operator’s stock valued at $6,924,000 after acquiring an additional 1,997 shares during the period. Finally, Gofen & Glossberg LLC IL raised its stake in shares of CVS Health by 1.8% in the 2nd quarter. Gofen & Glossberg LLC IL now owns 55,640 shares of the pharmacy operator’s stock valued at $4,477,000 after acquiring an additional 965 shares during the period. Institutional investors own 82.24% of the company’s stock.

Several brokerages recently weighed in on CVS. Loop Capital cut their target price on shares of CVS Health from $83.00 to $73.00 and set a “hold” rating on the stock in a research note on Tuesday, November 7th. Needham & Company LLC upped their target price on shares of CVS Health from $79.00 to $85.00 and gave the stock a “buy” rating in a research note on Monday, December 4th. Jefferies Group cut their target price on shares of CVS Health from $86.00 to $76.00 and set a “hold” rating on the stock in a research note on Tuesday, November 7th. Deutsche Bank began coverage on shares of CVS Health in a research note on Monday, December 4th. They set a “buy” rating and a $90.00 target price on the stock. Finally, Raymond James Financial reaffirmed a “buy” rating on shares of CVS Health in a research note on Monday, December 4th. One analyst has rated the stock with a sell rating, eight have issued a hold rating and fifteen have given a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $86.35.

CVS Health Corp (NYSE CVS) opened at $71.20 on Thursday. CVS Health Corp has a twelve month low of $66.45 and a twelve month high of $84.72. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.05 and a quick ratio of 0.55. The stock has a market cap of $73,842.05, a price-to-earnings ratio of 12.77, a PEG ratio of 1.37 and a beta of 0.89.

CVS Health (NYSE:CVS) last issued its earnings results on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.01. CVS Health had a net margin of 2.77% and a return on equity of 16.96%. The business had revenue of $46.18 billion during the quarter, compared to analysts’ expectations of $46.17 billion. During the same quarter in the prior year, the business posted $1.64 EPS. The company’s revenue for the quarter was up 3.5% on a year-over-year basis. sell-side analysts expect that CVS Health Corp will post 5.9 earnings per share for the current year.

In related news, EVP Helena Foulkes sold 39,340 shares of the stock in a transaction on Friday, September 15th. The shares were sold at an average price of $81.88, for a total transaction of $3,221,159.20. Following the completion of the sale, the executive vice president now owns 84,337 shares in the company, valued at approximately $6,905,513.56. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Thomas M. Moriarty sold 20,547 shares of the stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $81.17, for a total transaction of $1,667,799.99. Following the sale, the executive vice president now owns 43,178 shares of the company’s stock, valued at approximately $3,504,758.26. The disclosure for this sale can be found here. In the last quarter, insiders have sold 145,630 shares of company stock valued at $12,017,632. 0.61% of the stock is owned by company insiders.

ILLEGAL ACTIVITY NOTICE: This piece was posted by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The original version of this piece can be viewed at https://ledgergazette.com/2017/12/14/advisory-services-network-llc-acquires-4893-shares-of-cvs-health-corp-cvs.html.

CVS Health Profile

CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply